our story
Our journey began in 2010, when the earliest team members began to explore the idea of a diagnostic test that could be used by anyone, anywhere.
The concept
2010 - 2011
While completing an Entrepreneur-in-Residence at Artiman Ventures, Visby founder Adam de la Zerda explores the concept of a diagnostic so simple it could be used by anyone, anywhere.
Company founded
2012
After researching the market and finding nothing significant, Adam incorporates Click Diagnostics in December. Soon after, Greg Loney joins as a founding executive and the VP of engineering.
Focusing on sexual health
2013
Click Diagnostics explores a number of markets and identifies sexual health as the direction to pursue. Work begins on an STI test focused on women’s health.
First functional prototype
2017
Click Diagnostics develops its first fully integrated device. Small enough to fit in the palm of your hand, the PCR test delivers rapid and accurate results.
FDA clinical study
2019
NIH sponsors the FDA clinical study for the sexual health product.
Sexual Health Test - FDA submission
2020
Click Diagnostics submits its package to the FDA for its sexual health test. By mid-March, the team decides to join the fight against a new SARS pathogen, COVID-19.
Name change
2020
In March, Click Diagnostics officially becomes Visby Medical.
Visby Medical COVID-19 Test
2020
By July, Visby Medical has a functional COVID-19 test. It receives its first authorization from the FDA in September.
Visby Medical Sexual Health Test
2021
The Visby Medical Sexual Health Test (first generation) receives FDA clearance and CLIA waiver, making it the first instrument-free PCR test for the detection of Chlamydia, Gonorrhea, and Trichomoniasis.
Visby Medical Respiratory Health Test
2022
Visby Medical Respiratory Health Test receives Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for its point of care, instrument free PCR device that detects and differentiates between upper respiratory infections caused by Influenza (Flu) A & B, and SARS-CoV-2 (COVID-19).
Visby Medical Sexual Health Test
2023
Visby Medical Sexual Health Test (second generation) receives FDA clearance and CLIA waiver, making it the only instrument-free PCR test for the detection of Chlamydia, Gonorrhea, and Trichomoniasis.
Share Our Vision
At Visby, everyone’s voices and ideas are valued, because we know that our sum is only greater when each teammate’s whole self is brought to the table. If you’re ready to help usher in the future of diagnostics, check out our open roles today.
